120 related articles for article (PubMed ID: 18628084)
41. The role of CD11c expression in the diagnosis of mantle cell lymphoma.
Kraus TS; Sillings CN; Saxe DF; Li S; Jaye DL
Am J Clin Pathol; 2010 Aug; 134(2):271-7. PubMed ID: 20660331
[TBL] [Abstract][Full Text] [Related]
42. Diagnostic role and prognostic significance of a simplified immunophenotypic classification of mature B cell chronic lymphoid leukemias.
Cro L; Guffanti A; Colombi M; Cesana B; Grimoldi MG; Patriarca C; Goldaniga M; Neri A; Intini D; Cortelezzi A; Maiolo AT; Baldini L
Leukemia; 2003 Jan; 17(1):125-32. PubMed ID: 12529669
[TBL] [Abstract][Full Text] [Related]
43. Smoldering mantle cell lymphoma.
Ye H; Desai A; Zeng D; Nomie K; Romaguera J; Ahmed M; Wang ML
J Exp Clin Cancer Res; 2017 Dec; 36(1):185. PubMed ID: 29246179
[TBL] [Abstract][Full Text] [Related]
44. The Role of CD200 and CD43 Expression in Differential Diagnosis between Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma.
Falay M; Afacan Öztürk B; Güneş K; Kalpakçı Y; Dağdaş S; Ceran F; Özet G
Turk J Haematol; 2018 May; 35(2):94-98. PubMed ID: 28713070
[TBL] [Abstract][Full Text] [Related]
45. Low CD23 expression correlates with high CD38 expression and the presence of trisomy 12 in CLL.
Kriston C; Bödör C; Szenthe K; Bánáti F; Bánkuti B; Csernus B; Reiniger L; Csomor J; Matolcsy A; Barna G
Hematol Oncol; 2017 Mar; 35(1):58-63. PubMed ID: 26119874
[TBL] [Abstract][Full Text] [Related]
46. Immunophenotypic Variations in Mantle Cell Lymphoma and Their Impact on Clinical Behavior and Outcome.
Aqil B; Triska G; Frater J; Hassan A; Ruzinova MB; Cashen A; Reese Y; Kreisel F
Arch Pathol Lab Med; 2018 Oct; 142(10):1268-1274. PubMed ID: 29869903
[TBL] [Abstract][Full Text] [Related]
47. Circulating levels of soluble CD23 reflect clinical and biological features of leukemic B-cell chronic lymphoproliferative disorders.
Vinante F; Vassanelli A; Zanotti R; Nadali G; Krampera M; Vincenzi C; Morosato L; Chilosi M; Pizzolo G
Int J Clin Lab Res; 1995; 25(4):189-94. PubMed ID: 8788546
[TBL] [Abstract][Full Text] [Related]
48. Absolute monocyte count predicts overall survival in mantle cell lymphomas: correlation with tumour-associated macrophages.
Koh YW; Shin SJ; Park C; Yoon DH; Suh C; Huh J
Hematol Oncol; 2014 Dec; 32(4):178-86. PubMed ID: 24910369
[TBL] [Abstract][Full Text] [Related]
49. Minimal residual disease monitoring by 8-color flow cytometry in mantle cell lymphoma: an EU-MCL and LYSA study.
Cheminant M; Derrieux C; Touzart A; Schmit S; Grenier A; Trinquand A; Delfau-Larue MH; Lhermitte L; Thieblemont C; Ribrag V; Cheze S; Sanhes L; Jardin F; Lefrère F; Delarue R; Hoster E; Dreyling M; Asnafi V; Hermine O; Macintyre E
Haematologica; 2016 Mar; 101(3):336-45. PubMed ID: 26703963
[TBL] [Abstract][Full Text] [Related]
50. An unusual case of leukemic mantle cell lymphoma with a blastoid component showing loss of CD5 and aberrant expression of CD10.
Morice WG; Hodnefield JM; Kurtin PJ; Hanson CA
Am J Clin Pathol; 2004 Jul; 122(1):122-7. PubMed ID: 15272540
[TBL] [Abstract][Full Text] [Related]
51. Flow cytometric immunophenotyping analysis of patterns of antigen expression in non-Hodgkin's B cell lymphoma in samples obtained from different anatomic sites.
Gervasi F; Lo Verso R; Giambanco C; Cardinale G; Tomaselli C; Pagnucco G
Ann N Y Acad Sci; 2004 Dec; 1028():457-62. PubMed ID: 15650271
[TBL] [Abstract][Full Text] [Related]
52. Immunophenotyping of Chronic Lymphocytic Leukemia.
Falay M; Özet G
Clin Lab; 2017 Oct; 63(10):1621-1626. PubMed ID: 29035453
[TBL] [Abstract][Full Text] [Related]
53. T-cell levels are prognostic in mantle cell lymphoma.
Nygren L; Wasik AM; Baumgartner-Wennerholm S; Jeppsson-Ahlberg Å; Klimkowska M; Andersson P; Buhrkuhl D; Christensson B; Kimby E; Wahlin BE; Sander B
Clin Cancer Res; 2014 Dec; 20(23):6096-104. PubMed ID: 25294911
[TBL] [Abstract][Full Text] [Related]
54. Morphological spectrum of leukemic mantle cell lymphoma.
Rahman K; Subramanian PG; Kadam PA; Gadage V; Galani K; Mittal N; Ghogale S; Badrinath Y; Ansari R; Kushte S; Nair R; Sengar M; Menon H; Gujral S
Indian J Pathol Microbiol; 2012; 55(1):66-71. PubMed ID: 22499304
[TBL] [Abstract][Full Text] [Related]
55. Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network.
Hoster E; Klapper W; Hermine O; Kluin-Nelemans HC; Walewski J; van Hoof A; Trneny M; Geisler CH; Di Raimondo F; Szymczyk M; Stilgenbauer S; Thieblemont C; Hallek M; Forstpointner R; Pott C; Ribrag V; Doorduijn J; Hiddemann W; Dreyling MH; Unterhalt M
J Clin Oncol; 2014 May; 32(13):1338-46. PubMed ID: 24687837
[TBL] [Abstract][Full Text] [Related]
56. Clinicopathologic features and management of blastoid variant of mantle cell lymphoma.
Shrestha R; Bhatt VR; Guru Murthy GS; Armitage JO
Leuk Lymphoma; 2015; 56(10):2759-67. PubMed ID: 25747972
[TBL] [Abstract][Full Text] [Related]
57. Guess what: Chronic 13q14.3+/CD5-/CD23+ lymphocytic leukemia in blood and t(11;14)(q13;q32)+/CD5+/CD23- mantle cell lymphoma in lymph nodes!
Lima M; Pinto L; Dos Anjos Teixeira M; Canelhas A; Mota A; Cabeda JM; Silva C; Queirós ML; Fonseca S; Santos AH; Brochado P; Justiça B
Cytometry B Clin Cytom; 2003 Jan; 51(1):41-4. PubMed ID: 12500296
[TBL] [Abstract][Full Text] [Related]
58. Multiparameter immunohistochemical analysis of the cell cycle proteins cyclin D1, Ki-67, p21WAF1, p27KIP1, and p53 in mantle cell lymphoma.
Izban KF; Alkan S; Singleton TP; Hsi ED
Arch Pathol Lab Med; 2000 Oct; 124(10):1457-62. PubMed ID: 11035575
[TBL] [Abstract][Full Text] [Related]
59. miR-18b overexpression identifies mantle cell lymphoma patients with poor outcome and improves the MIPI-B prognosticator.
Husby S; Ralfkiaer U; Garde C; Zandi R; Ek S; Kolstad A; Jerkeman M; Laurell A; Räty R; Pedersen LB; Pedersen A; Ehinger M; Sundström C; Karjalainen-Lindsberg ML; Delabie J; Clasen-Linde E; Brown P; Cowland JB; Workman CT; Geisler CH; Grønbæk K
Blood; 2015 Apr; 125(17):2669-77. PubMed ID: 25736311
[TBL] [Abstract][Full Text] [Related]
60. Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network.
Hoster E; Rosenwald A; Berger F; Bernd HW; Hartmann S; Loddenkemper C; Barth TF; Brousse N; Pileri S; Rymkiewicz G; Kodet R; Stilgenbauer S; Forstpointner R; Thieblemont C; Hallek M; Coiffier B; Vehling-Kaiser U; Bouabdallah R; Kanz L; Pfreundschuh M; Schmidt C; Ribrag V; Hiddemann W; Unterhalt M; Kluin-Nelemans JC; Hermine O; Dreyling MH; Klapper W
J Clin Oncol; 2016 Apr; 34(12):1386-94. PubMed ID: 26926679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]